NEW YORK, April 23 – Cepheid of Sunnyvale, Calif., said Monday its more than tripled to $3.3 in first-quarter 2001, compared with $900,000 in the year ago period.

Cepheid attributed the increase in revenues to initial sales of its SmartCycler DNA testing system, which the company began selling through distributors in May of 2000. In January, the company began receiving revenue from sales of the SmartCycler in Europe, sold through its Belgian distributor, Eurogentec.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.